BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 25689483)

  • 1. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
    Wang L; Xue M; Chung DC
    Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
    Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
    Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells.
    Zhang Z; Chen L; Yang Q; Tang X; Li J; Zhang G; Wang Y; Huang H
    Int J Biochem Cell Biol; 2024 Jun; 171():106570. PubMed ID: 38588888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
    Yang C; Pan Y; Deng SP
    BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of small interfering RNA targeting c-myc in combination with 5-fluorouracil on the growth in vitro and in vivo].
    Sang JZ; Wang HT; Lou WH; Tian F; Jin HJ; Yuan LL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 46(7):566-71. PubMed ID: 22088286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
    González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
    Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients.
    Wilson BJ; Schatton T; Zhan Q; Gasser M; Ma J; Saab KR; Schanche R; Waaga-Gasser AM; Gold JS; Huang Q; Murphy GF; Frank MH; Frank NY
    Cancer Res; 2011 Aug; 71(15):5307-16. PubMed ID: 21652540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
    Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
    Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo.
    Xie Q; Wu MY; Zhang DX; Yang YM; Wang BS; Zhang J; Xu J; Zhong WD; Hu JN
    World J Gastroenterol; 2016 Aug; 22(32):7342-52. PubMed ID: 27621580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
    Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
    He J; Xie G; Tong J; Peng Y; Huang H; Li J; Wang N; Liang H
    Cell Biochem Biophys; 2014 Nov; 70(2):1343-50. PubMed ID: 24898807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.